Figure 4. Cumulative event curves for in‐hospital mortality among hypertensive individuals with hospitalization for COVID‐19 during May to August, 2020 (secondary inpatient cohort) comparing (A) ACE inhibitor vs other; (B) ARB vs other; and (C) ACE inhibitor vs ARB.

Plots represent propensity score–matched groups. ACE indicates angiotensin‐converting enzyme; and ARB, angiotensin receptor blocker.